Ground Swell Capital’s Protalix BioTherapeutics PLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-62,234	Closed	-$72.8K	–	239
2024 Q2	$72.8K	Buy	+62,234	New	+$72.8K	0.06%	93
2021 Q2	–	Sell	-14,684	Closed	-$65K	–	137
2021 Q1	$65K	Buy	+14,684	New	+$65K	0.21%	82